## KEY TAKEAWAYS
- KKR & Co. Inc., through affiliate Tarheel Investors III L.P., holds a 14.0% stake in Integer Holdings Corporation (NYSE: ITGR), reportable after equity swaps settled on Oct. 5, 2026.
- The stake was disclosed in a Schedule 13D filed Oct. 13, 2026, alongside a definitive merger agreement signed Aug. 2, 2026 for KKR affiliates to acquire Integer.
- Integer shareholders will receive $127 per share in cash at closing, a transaction valued at approximately $5.7 billion according to the announcement.
- Tarheel settled physically settled swaps for 4,753,677 shares and holds a cash-settled swap tied to 836,392 shares that carries no voting rights.
- A KKR affiliate has committed equity to fund the merger consideration and provided a limited guarantee covering certain obligations of the acquisition vehicle; closing remains subject to customary conditions, including stockholder and regulatory approvals.
## DETAILED SUMMARY
KKR & Co. Inc. has acquired a 14.0% economic and beneficial position in Integer Holdings Corporation, a Plano, Texas-based medical device contract development and manufacturing organization, according to a Schedule 13D filed with the SEC on Oct. 13, 2026. The position was acquired through Tarheel Investors III L.P., a KKR affiliate, after equity swaps settled on Oct. 5, 2026, which triggered the reporting obligation.
The disclosed stake is closely tied to a take-private transaction. KKR affiliates agreed to acquire Integer under a definitive merger agreement signed Aug. 2, 2026. Under the terms, each outstanding share of common stock will be converted into the right to receive $127 in cash at the effective time, subject to customary closing conditions. The announcement values the transaction at approximately $5.7 billion and represents a premium of approximately 51.8% to Integer's pre-announcement share price, per the publisher's transaction disclosure.
According to the filing, Tarheel settled physically settled swaps to acquire 4,753,677 shares. It also holds a cash-settled swap referencing 836,392 shares, which confers no voting rights. To finance the transaction, a KKR affiliate has committed to invest the equity required to enable the acquisition vehicle to pay the merger consideration, and has provided a limited guarantee covering certain obligations of that vehicle.
KKR, a Delaware corporation and global investment firm with private equity, credit, and real assets strategies, has a track record in large-scale buyouts across healthcare and medical technology. The transaction is expected to be completed as a take-private, removing Integer from public markets upon closing. Completion remains subject to stockholder approval and regulatory clearances.
